Literature DB >> 10980064

Quality of life and cognitive function of liver transplant patients: a prospective study.

K A Moore1, R McL Jones, G D Burrows.   

Abstract

The presence of cognitive impairment in end-stage liver disease is well recognized, as are patient reports of an impoverished quality of life. The aim of this study is to systematically evaluate the effect of orthotopic liver transplantation (OLT) on these factors. Thirty-two adult patients activated for OLT participated in the study. Assessments were made on activation and at 1, 3, and 9 months post-OLT, with 24 transplant recipients available for reassessment at 9 months. Two control groups (10 patients with nonalcoholic cirrhosis and 10 healthy volunteers) also completed the test protocol at four 2-month intervals. The test battery included the Austin Quality-of-Life Scale, Weschler Adult Intelligence Scale-Revised, Benton's Controlled Oral Word Test, and the Complex Figure of Rey. The OLT group showed significant improvement in cognitive performance and their reported quality of life. These changes were evident by 3 month post-OLT and remained stable at subsequent testing. The control groups typically remained stable over test occasions. Clearly, OLT extends life and, most importantly, improves patients' quality of life and their cognitive functioning.

Entities:  

Mesh:

Year:  2000        PMID: 10980064     DOI: 10.1053/jlts.2000.9743

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  10 in total

Review 1.  Neurologic complications after liver transplantation.

Authors:  Saša A Zivković
Journal:  World J Hepatol       Date:  2013-08-27

Review 2.  Hepatic encephalopathy: a dynamic or static condition.

Authors:  Charmaine A Stewart; Jane Cerhan
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

3.  Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.

Authors:  Jolanta Sumskiene; Linas Sumskas; Dalius Petrauskas; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

4.  Impact of previous episodes of hepatic encephalopathy on short-term brain function recovery after liver transplantation: a functional connectivity strength study.

Authors:  Yue Cheng; Gaoyan Zhang; Wen Shen; Li-Xiang Huang; Li Zhang; Shuang-Shuang Xie; Xiao-Dong Zhang; Baolin Liu
Journal:  Metab Brain Dis       Date:  2017-11-23       Impact factor: 3.584

Review 5.  Neurocognitive-neurological complications of liver transplantation: a review.

Authors:  Francesca Campagna; A Biancardi; U Cillo; A Gatta; P Amodio
Journal:  Metab Brain Dis       Date:  2010-03-05       Impact factor: 3.584

6.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

7.  Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy.

Authors:  Rajat Dhar; G Bryan Young; Paul Marotta
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.

Authors:  Chathur Acharya; James B Wade; Andrew Fagan; Melanie White; Edith Gavis; Dinesh Ganapathy; HoChong Gilles; Douglas M Heuman; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2017-11       Impact factor: 5.799

Review 9.  Outcomes in liver transplantation: does sex matter?

Authors:  Monika Sarkar; Kymberly D Watt; Norah Terrault; Marina Berenguer
Journal:  J Hepatol       Date:  2014-11-27       Impact factor: 25.083

10.  The Perception of Medical Students at King Abdulaziz University Hospital Regarding the Liver Transplant Allocation System.

Authors:  Mohammed A Safhi; Mohammed Alzahrani; Khaled W Altahini; Abdulaziz Kilfaden; Abdulrahman A Bagber; Mohammed R Algethami; Wisam Jamal; Hisham Rizk
Journal:  Cureus       Date:  2019-11-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.